Recognising The Warning Signs Of ADHD
Aug 5, 2020
The Attention deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder that affects children and teens. ADHD is mostly recognised during the early sch...
Read More
MorphoSys, Incyte receive FDA Ok for Monjuvi; Siemens Healthineers set to buy Varian; Immunic’s IMU-838 promising results
Aug 4, 2020
MorphoSys, Incyte gets an early FDA nod for Monjuvi, an alternative to CAR-T for B-cell malignancies MorphoSys and Incyte announced the US FDA approval under accelerated ap...
Read More
Enough Of Wasting Away From Cancer: Companies Gear Up To Tackle Cachexia
Aug 3, 2020
The dynamics of the cancer cachexia market is expected to gain momentum as several companies are testing the waters, advancing cancer cachexia pipeline. More than half of t...
Read More
A Complex Chromosomal Abberation Called Adrenoleukodystrophy
Jul 31, 2020
The global Adrenoleukodystrophy market size for the forecast period 2020-30, which was estimated to be USD 922.43 million in the 7MM in 2017 is driven by key pharma players...
Read More
Roche-UCB’s $120M collaboration; Omega snags $85M; ExeVir raises $27M; GSK culls pipeline meds after failures
Jul 30, 2020
Roche bets USD 120 Million on UCB’s anti-tau Alzheimer’s antibody The Swiss pharma, Roche, is handing over USD 120 million upfront for the right of UCB’s ...
Read More
In The Global Race For The COVID-19 Vaccine, India Stands As A Strong Player
Jul 29, 2020
India registered its first COVID-19 case on 30-January-2020 in Kerala. The cases since then are on a continuous rise. The Government of India in order to contain the spread...
Read More
AZ, Daiichi inks an oncology deal; Moderna begins Phase III trial of its COVID-19 vaccine; No good news for Solid’s DMD gene therapy trial
Jul 28, 2020
AZ, Daiichi put their trust into TROP2-based drugs, inks an oncology deal to together develop and commercialize DS-1062 AstraZeneca has inked an oncology deal with Daiichi ...
Read More
Addressing The Scattered Harbingers of Frontotemporal Dementia
Jul 27, 2020
The Frontotemporal dementia market is expected to increase with a CAGR of 21.41% for 7MM during the study period. However, pharma companies such as TauRx Therapeutics, Axon...
Read More
Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy Effective Enough, Affordable Enough
Jul 24, 2020
The current Familial chylomicronemia syndrome market is mainly dominated by traditional TG-lowering agents, and as per DelveInsight analysis, the market worth was estimated...
Read More
Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis and Chugai’s Collaboration; A new study on averting heart attack
Jul 23, 2020
Olema Oncology raises USD 54 Million for breast cancer program Olema Oncology has raised USD 54 million to push its lead program into the clinic and boost its R&D effor...
Read More
Ways IoT Has Transformed The Pulse Of Healthcare, And Will Continue To Do So In The Future
Jul 22, 2020
The technology over the past few years has opened many new avenues and possibilities that have radically transformed the healthcare industry’s outlook. Today the tech-bas...
Read More
AZ shows positive results for its COVID-19 vaccine; Synairgen offers a new approach to address COVID; GSK, CureVac forms mRNA strategic partnership
Jul 21, 2020
AstraZeneca demonstrates positive early results from its trial evaluating COVID-19 vaccine-AZD1222 In a frenzied race to find a global cure for COVID-19, several pharma pla...
Read More
Watch Out for the Most Promising Therapies in the Pipeline in Acute Kidney Injury Market
Jul 20, 2020
The Acute Kidney Injury Therapies in the pipeline anticipated to launch in the next decade shall spur the AKI Market growth forward. Acute Kidney Injury (AKI) is defined as...
Read More
An Eye-Blinding Scenario of Vernal keratoconjunctivitis
Jul 17, 2020
The present Vernal keratoconjunctivitis market size in all the markets (the US, EU-5 (Germany, France, Italy, Spain, United Kingdom), Japan, China, MEA (Saudi Arabia, Egypt...
Read More
Orchard licenses gene therapy tech from GSK; Glympse raises $46M; FDA voted to recommend Terlipressin; Breast Cancer research update
Jul 16, 2020
Orchard licenses the gene therapy technology from GlaxoSmithKline Orchard Therapeutics has permitted lentiviral stable cell line technology from GlaxoSmithKline for i...
Read More
